Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 402957-28-2
Drug Levels and Effects
Summary of Use during Lactation
Telaprevir is no longer marketed in the United States and has not been studied in nursing mothers. Because it must be used with ribavirin and peginterferon alfa, it is not considered a good choice during breastfeeding. When it was marketed, the manufacturer recommended that mothers taking telaprevir not breastfeed their infants.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Hepatitis C) Interferon Alfa, Interferon Alfacon-1
Substance Identification
Substance Name
Telaprevir
CAS Registry Number
402957-28-2
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Boceprevir.[Drugs and Lactation Database (...]Review Boceprevir.. Drugs and Lactation Database (LactMed®). 2006
- Telaprevir: helical chains based on three-point hydrogen-bond connections.[Acta Crystallogr C. 2013]Telaprevir: helical chains based on three-point hydrogen-bond connections.Gelbrich T, Kahlenberg V, Langes C, Griesser UJ. Acta Crystallogr C. 2013 Feb; 69(Pt 2):179-82. Epub 2013 Jan 16.
- Review Peginterferon Alfa.[Drugs and Lactation Database (...]Review Peginterferon Alfa.. Drugs and Lactation Database (LactMed®). 2006
- Review Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.[Drugs. 2012]Review Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.Perry CM. Drugs. 2012 Mar 26; 72(5):619-41.
- Review Ramipril.[Drugs and Lactation Database (...]Review Ramipril.. Drugs and Lactation Database (LactMed®). 2006
- Telaprevir - Drugs and Lactation Database (LactMed®)Telaprevir - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...